Targeting PI3K/AKT/mTOR canbe used as a potent antineoplastic therapeutic method via the suppression of the pathway using flavonoids, which permits the inactivation of mTOR, the induction of autophagy, and the gastric tumor cell death by stopping them in the M/G2 cycle checkpoint [61]. This evidence concerns the gene MTOR and gastric neoplasm.